Adriamycin (Doxorubicin) Cardiotoxicity: A Review

Por Chlebowski, Rowan T.
Publicado em 1979

Vitamin D and breast cancer: interpreting current evidence

Por Chlebowski, Rowan T
Publicado em 2011

Changing Concepts: Menopausal Hormone Therapy and Breast Cancer

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado em 2012

Menopausal Hormone Therapy and Cancer: Changing Clinical Observations of Target Site Specificity

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado em 2014

Menopausal hormone therapy and breast cancer mortality: clinical implications

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado no Ther Adv Drug Saf (2015)

Utility of Two Cancer Organization Websites for a Multiethnic, Public Hospital Oncology Population: Comparative Cross-Sectional Survey

Por Nguyen, Katherine D, Hara, Belinda, Chlebowski, Rowan T
Publicado em 2005

Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence

Por Col, Nananda F, Kim, Jung A, Chlebowski, Rowan T
Publicado em 2005

Alcohol use and breast cancer survival among participants in the Women's Health Initiative

Por Lowry, Sarah J., Kapphahn, Kris, Chlebowski, Rowan, Li, Christopher I.
Publicado no Cancer Epidemiol Biomarkers Prev (2016)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005

Por Yasmeen, Shagufta, Chlebowski, Rowan T, Xing, Guibo, Morris, Cyllene R, Romano, Patrick S
Publicado em 2013

Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors

Por Chlebowski, Rowan T., Schottinger, Joanne E., Shi, Jiaxiao, Chung, Joanie, Haque, Reina
Publicado no Cancer (2015)

Body Mass Index and Waist Circumference in Relation to Lung Cancer Risk in the Women's Health Initiative

Por Kabat, Geoffrey C., Kim, Mimi, Hunt, Julie R., Chlebowski, Rowan T., Rohan, Thomas E.
Publicado em 2008

HIP BONE DENSITY PREDICTS BREAST CANCER RISK INDEPENDENTLY OF GAIL SCORE-RESULTS FROM THE WOMEN’S HEALTH INITIATIVE

Por Chen, Zhao, Arendell, Leslie, Aickin, Mikel, Cauley, Jane, Lewis, Cora E., Chlebowski, Rowan
Publicado em 2008

Meta-analysis of Vascular and Neoplastic Events Associated with Tamoxifen

Por Braithwaite, R Scott, Chlebowski, Rowan T, Lau, Joseph, George, Suzanne, Hess, Rachel, Col, Nananda F
Publicado em 2003

Diabetes and Lung Cancer Among Postmenopausal Women

Por Luo, Juhua, Chlebowski, Rowan, Wactawski-Wende, Jean, Schlecht, Nicolas F., Tinker, Lesley, Margolis, Karen L.
Publicado em 2012

SNPs and breast cancer risk prediction for African American and Hispanic women

Por Allman, Richard, Dite, Gillian S., Hopper, John L., Gordon, Ora, Starlard-Davenport, Athena, Chlebowski, Rowan, Kooperberg, Charles
Publicado no Breast Cancer Res Treat (2015)

Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women

Por Bodelon, Clara, Anderson, Garnet L., Rossing, Mary Anne, Chlebowski, Rowan T., Ochs-Balcom, Heather M., Vaughan, Thomas L.
Publicado em 2011

Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women’s Health Initiative

Por Kaklamani, Virginia G., Hoffmann, Thomas J., Thornton, Timothy A., Hayes, Geoffrey, Chlebowski, Rowan, Van Horn, Linda, Mantzoros, Christos
Publicado em 2013

Oral bisphosphonate use and colorectal cancer incidence in the Women’s Health Initiative

Por Passarelli, Michael N., Newcomb, Polly A., LaCroix, Andrea Z., Lane, Dorothy S., Ho, Gloria Y.F., Chlebowski, Rowan T.
Publicado em 2013

Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women

Por Luo, Juhua, Chlebowski, Rowan, Liu, Simin, McGlynn, Katherine A, Parekh, Niyati, White, Donna L, Margolis, Karen L
Publicado em 2012

Metformin and breast and gynecological cancer risk among women with diabetes

Por Soffer, Diana, Shi, Jiaxiao, Chung, Joanie, Schottinger, Joanne E, Wallner, Lauren P, Chlebowski, Rowan T, Lentz, Scott E, Haque, Reina
Publicado no BMJ Open Diabetes Res Care (2015)